EGF and cancer: The role of chemoattractants (e.g., EGF) and surface receptors (e.g., EphA2) as driving molecules controlling cell adhesion and migration in cancer has been a focus of study for many years, and has been exploited for targeting of drug delivery and cancer treatment.